LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...

Please provide your email address to receive an email when new articles are posted on . Intraocular lens surgery was once seen as a last resort for patients interested in spectacle independence, but ...

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today ...

Please provide your email address to receive an email when new articles are posted on . A 36-year-old Hispanic man presented to the refractive surgery clinic at the New England Eye Center for surgical ...

New FDA expansion of U.S. age indication extends EVO ICL use for patients 21 to 60 years old – making EVO ICL available to nearly 8 million additional refractive patients Lens-based vision correction ...

All right, let's take *** look panel. Robinson has used corrective lenses since first grade. Now working as *** cinematographer and director. His contacts had become *** constant misery. The ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICLTM) for myopia, astigmatism and presbyopia, is proud to ...

In March 2022, the U.S. Food and Drug Administration (FDA) granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism. Myopia is ...

FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction New FDA expansion of U.S. age indication extends EVO ICL use for patients ...